ABERA — Abera Bioscience AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK115.88m
- SEK92.39m
Annual cashflow statement for Abera Bioscience AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.16 | -19.4 | -16.8 | -1.12 | -10.6 |
| Depreciation | |||||
| Changes in Working Capital | -0.516 | -0.299 | -0.91 | 0.861 | 7.13 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.68 | -19.7 | -17.7 | -0.198 | -3.26 |
| Capital Expenditures | — | — | — | -1.13 | -0.426 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -0.025 | — | — |
| Acquisition of Business | |||||
| Cash from Investing Activities | — | — | -0.025 | -1.13 | -0.426 |
| Financing Cash Flow Items | -2.37 | -0.892 | -0.009 | -0.1 | -0.417 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.7 | 23.2 | 5.6 | 4.1 | 21.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11 | 3.48 | -12.1 | 2.77 | 17.4 |